Clinical Trials Directory

Trials / Unknown

UnknownNCT02665494

Biliary Cancer in Italy: a Study on Cholangiocarcinoma cAUSEs and Risk Factors

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Fondazione del Piemonte per l'Oncologia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Multi-centric, observational, prospective study, designed for pts with diagnosis of all-stages cholangiocarcinoma, including rare and crossing-over histological types, and excluding gallbladder cancer and ampullary carcinoma.

Detailed description

Patients will undergo basal blood sample exams regarding blood cell count, renal and liver function, tumor markers, inflammatory and metabolic state, along with a screening (and, if needed, a more in-depth laboratory analysis) for viral hepatitis infections. Information will be collected about radiological, clinical and pathological features of the neoplasm at time of diagnosis, as well, at a later time, about its natural history. A two-step data analysis will be performed: Task-1 analysis will define the risk factors landscape, Task-2 analysis will examine the influence of etiology on clinical outcomes. Anonymized data will be stored in a central database, kept at the Leading Centre.

Conditions

Timeline

Start date
2016-01-01
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2016-01-27
Last updated
2016-09-23

Locations

12 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT02665494. Inclusion in this directory is not an endorsement.

Biliary Cancer in Italy: a Study on Cholangiocarcinoma cAUSEs and Risk Factors (NCT02665494) · Clinical Trials Directory